As a reminder from our last post, one of the active hip litigations right now is BHR. Plaintiffs have asserted product liability claims against Smith...
In a July 30, 2018 Safety Communication , the FDA warned women considering elective vaginal “rejuvenation” procedures (and the health care providers who perform these...
We have an update from the MDL (multidistrict litigation) regarding recent decisions and activities. Of the 120,000 cases filed, 5,000 remain unsettled. The Judge is...
We recently updated you about Bayer's recent market withdrawal. There's been a recent court decision that provides another set back for the company. This time...
We recently wrote about medical device litigation involving some defective hip replacements; specifically, the Smith & Nephew Birmingham Hip Resurfacing System (BHR) device. Another lawsuit...
The FDA has approved new labeling for Orbera and ReShape intragastric balloon systems after possible deaths have been reported. These balloons are weight-loss systems used...
